[{"Assets_0_Q3_USD":2865918000.0,"CommonStockSharesOutstanding_0_Q3_shares":47324000.0,"EarningsPerShareBasic_1_Q3_USD":1.11,"EarningsPerShareBasic_3_Q3_USD":3.22,"EarningsPerShareDiluted_1_Q3_USD":1.08,"EarningsPerShareDiluted_3_Q3_USD":3.16,"NetIncomeLoss_1_Q3_USD":52474000.0,"NetIncomeLoss_3_Q3_USD":153204000.0,"StockholdersEquity_0_Q3_USD":1021513000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":48390000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":48440000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":47451000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":47530000.0,"Ticker":"CRL","CIK":"1100682","name":"CHARLES RIVER LABORATORIES INTERNATIONAL INC","OfficialName":"Charles River Laboratories International Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14658056932.0","Country":"United States","Sector":"Consumer Services","Industry":"EDP Services","Market":"NYSE","SP500":"SP500","filed":"20171109"}]